SV2008003080A - Formulacion de medicamento liquida - Google Patents

Formulacion de medicamento liquida

Info

Publication number
SV2008003080A
SV2008003080A SV2008003080A SV2008003080A SV2008003080A SV 2008003080 A SV2008003080 A SV 2008003080A SV 2008003080 A SV2008003080 A SV 2008003080A SV 2008003080 A SV2008003080 A SV 2008003080A SV 2008003080 A SV2008003080 A SV 2008003080A
Authority
SV
El Salvador
Prior art keywords
formulation
medicinal product
liquid medicinal
liquid
betablockers
Prior art date
Application number
SV2008003080A
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Gerald Beddies
Georg Schulte
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of SV2008003080A publication Critical patent/SV2008003080A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCIÓN SE REFIERE A UNA FORMULACIÓN DE MEDICAMENTO LÍQUIDA PARA BETABLOQUEANTES QUE ES ESPECIALMENTE ADECUADA PARA LA ADMINISTRACIÓN POR VÍA ORAL EN ANIMALES
SV2008003080A 2006-05-02 2008-10-29 Formulacion de medicamento liquida SV2008003080A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006020604A DE102006020604A1 (de) 2006-05-02 2006-05-02 Flüssige Arzneimittelformulierung

Publications (1)

Publication Number Publication Date
SV2008003080A true SV2008003080A (es) 2009-11-26

Family

ID=38180418

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2008003080A SV2008003080A (es) 2006-05-02 2008-10-29 Formulacion de medicamento liquida

Country Status (23)

Country Link
US (1) US20090264535A1 (es)
EP (1) EP2015728A2 (es)
JP (1) JP2009535368A (es)
KR (1) KR20090014183A (es)
CN (1) CN101431981A (es)
AR (1) AR060730A1 (es)
AU (1) AU2007245911A1 (es)
BR (1) BRPI0711140A2 (es)
CA (1) CA2650786A1 (es)
CO (1) CO6180495A2 (es)
CR (1) CR10407A (es)
DE (1) DE102006020604A1 (es)
EC (1) ECSP088850A (es)
GT (1) GT200800235A (es)
IL (1) IL195034A0 (es)
MX (1) MX2008013873A (es)
PE (1) PE20080149A1 (es)
RU (1) RU2008147216A (es)
SV (1) SV2008003080A (es)
TW (1) TW200808373A (es)
UY (1) UY30315A1 (es)
WO (1) WO2007124869A2 (es)
ZA (1) ZA200809269B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011507918A (ja) * 2007-12-27 2011-03-10 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング β−遮断薬を使用する心疾患の処置
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
KR20150120008A (ko) * 2014-04-16 2015-10-27 씨제이헬스케어 주식회사 비소프롤롤 및 로수바스타틴을 포함하는 경구용 약제학적 복합제제
MX2017011257A (es) 2015-03-03 2018-04-10 Saniona As Formulacion de combinacion de tesofensina y betabloqueante.
GB202207690D0 (en) * 2022-05-25 2022-07-06 Zentiva Ks Liquid pharmaceutical formulation of bisoprolol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
US4600708A (en) * 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
ES2293875T3 (es) * 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
US6645963B2 (en) * 1997-11-05 2003-11-11 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
US6664284B2 (en) * 1998-07-23 2003-12-16 Roche Diagnostics Gmbh Stabilized carvedilol injection solution
WO2003028718A1 (en) * 2001-10-01 2003-04-10 Smithkline Beecham Corporation Novel formulations of carvedilol

Also Published As

Publication number Publication date
UY30315A1 (es) 2007-11-30
CR10407A (es) 2009-03-30
US20090264535A1 (en) 2009-10-22
CO6180495A2 (es) 2010-07-19
EP2015728A2 (de) 2009-01-21
KR20090014183A (ko) 2009-02-06
MX2008013873A (es) 2008-11-14
WO2007124869A2 (de) 2007-11-08
ECSP088850A (es) 2008-12-30
IL195034A0 (en) 2009-08-03
DE102006020604A1 (de) 2007-11-08
GT200800235A (es) 2010-04-28
TW200808373A (en) 2008-02-16
RU2008147216A (ru) 2010-06-10
AU2007245911A1 (en) 2007-11-08
WO2007124869A3 (de) 2008-04-17
CA2650786A1 (en) 2007-11-08
BRPI0711140A2 (pt) 2011-08-23
CN101431981A (zh) 2009-05-13
ZA200809269B (en) 2009-12-30
PE20080149A1 (es) 2008-04-06
AR060730A1 (es) 2008-07-10
JP2009535368A (ja) 2009-10-01

Similar Documents

Publication Publication Date Title
CO6680698A2 (es) Formulación de premezcla de dexmedetomidina
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
BRPI0516238A (pt) composição farmacêutica contendo diclofenaco
CL2007002228A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composiicon empacada; metodos para esterelizarlas; util para cicatrizar tejido donde la dermis se ha desgarrado.
BRPI0719486A2 (pt) "forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente"
GT201100127A (es) Moduladores de aril metil benzoquinazolinona alostéricos positivos del receptor m1
CL2007002095A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composicion empacada; metodo para esterilizarla; util para cicatrizar tejido donde la dermis se ha desgarrado.
ECSP10010433A (es) Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas
SG162798A1 (en) Liquid pharmaceutical formulations of docetaxel
CL2012002424A1 (es) Método para tratar artitris reumatoide que comprende administrar al paciente laquinimod y metotrexato por vía oral; composición farmacéutica que los comprende.
GT201400059A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos
CY1118032T1 (el) Διεργασιες για την εμπορικη παρασκευη φαρμακευτικα δραστικου παραγοντα
HN2008001666A (es) Derivados acidos de cicloalquilamino
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
SV2008003080A (es) Formulacion de medicamento liquida
CO6382089A2 (es) Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias
PE20150353A1 (es) Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
BR112014014795A2 (pt) sistema de pélete de multiunidade de liberação imediata
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
CR20130318A (es) Nuevos compuestos de benzodioxol-piperazina
UY31000A1 (es) Oxoisoxazoles como inhibidores de lipasas y fosfolipasas
MA32635B1 (fr) Produit medicamenteux et traitement associe
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção

Legal Events

Date Code Title Description
FD Lapse